SFS Group

SFS sticks to its targets for 2026 and expects sales growth in local currencies of 3 to 6 percent as well as a normalized EBIT margin of 12 to 15 percent, including consolidation effects. Ahead of the biennial Investor Day, group management will provide deeper insights into the Engineered Components, Fastening Systems and Distribution & Logistics segments. CFO Volker Dostmann will also report on the seven‑year bond of CHF 250 million placed in early September with a 1.2% coupon. » Altro su finanzen.net

UBS cut SFS from "Buy" to "Neutral", citing the strong share rally. At the same time the bank raised its price target from CHF 130 to CHF 145 and slightly increased earnings and free cash flow estimates for 2026–27. SFS shares fell about 7.6%; UBS warns of a weakening in organic revenue growth and stagnating margins in the second half of 2026 and believes efficiency measures are already priced in. End markets are mixed: slightly declining auto production, but a projected recovery in construction in 2027. » Altro su de.investing.com

The SFS share fell about 7.6% to CHF 129.2 after UBS cut its rating from "Buy" to "Neutral", assessing the risk-reward as balanced following the recent price rise. The bank did raise its price target to CHF 145 and increased its earnings estimates for 2026–27, but warned of a slowdown in earnings momentum in the second half of the year. SFS had reported strong half-year figures: adjusted EBIT of CHF 206 million (+22.5%) and organic revenue growth of 4.0%, which beat analysts' expectations, but that was not enough to stop the selling pressure after the reassessment. » Altro su de.investing.com

SFS reports H1 2026 sales of CHF 1,559.3 million and a normalized EBIT margin of 13.3%, thereby exceeding its growth targets. Several acquisitions successfully complemented organic growth and contributed to the progress. » Altro su de.investing.com

The Swiss stock market closed slightly higher on Friday; the SMI gained 0.1 percent to 14,235 points as investors remained cautious ahead of the weekend and amid renewed flare-ups in the Middle East. Support came from the chip sector due to large AI investment plans. Novartis and Roche remained steady, while Nestlé fell 0.2 percent. SFS Group rose 3.3 percent after acquiring Heartland Precision Fasteners to bolster its US operations; no financial details were disclosed. » Altro su finanzen.net